PMCB
PharmaCyte Biotech, Inc.
$0.7610
+1.45%
$8.2M
No data for this timeframe.
Vol
Market Cap$8.2M
Cap SizeNano Cap
Inst. Holders11 funds
Inst. Value$441.3K
Inst. Activity0 buys / 3 sells
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. NV·CIK 0001157075·Prev Close $0.7501
Recent Activity
Mar 31, 2026
Insider
Abecassis Michael M was granted 119,170 shares
Director
Mar 31, 2026
Insider
SCHECHTER JONATHAN was granted 119,170 shares
Director
Mar 31, 2026
Insider
WEINSTEIN ROBERT was granted 119,170 shares
Director
Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
56,500 shares ($37.6K)
Inst.
HRT FINANCIAL LP — NEAR_EXIT
24,741 shares ($16.00)
Mar 16, 2026
earnings_calendar
PMCB Q3 2026 Earnings Scheduled — 2026-03-16
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 8, 2021 | HC Wainwright & Co. | INITIATE | Neutral |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $239.2K | — |
| CITADEL ADVISORS LLC | $106.6K | — |
| RENAISSANCE TECHNOLOGIES LLC | $37.6K | TRIM |
| VANGUARD CAPITAL MANAGEMENT LLC | $34.2K | — |
| VANGUARD FIDUCIARY TRUST CO | $15.6K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 31, 2026 | Abecassis Michael | A | $0.00 |
| Mar 31, 2026 | SCHECHTER JONATHAN | A | $0.00 |
| Mar 31, 2026 | WEINSTEIN ROBERT | A | $0.00 |
| Mar 31, 2026 | WALKER WAYNE | A | $0.00 |
11 institutional holders with $441.3K total value (688,008 shares) as of 2026-Q1. Top holders: CITADEL, CITADEL, RENAISSANCE. Net selling activity: 3 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 359,547 | $239.2K | 54.2% | — |
| 2 | CITADEL ADVISORS LLC | 160,200 | $106.6K | 24.2% | — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 56,500 | $37.6K | 8.5% | TRIM -39.9% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 51,467 | $34.2K | 7.8% | — |
| 5 | VANGUARD FIDUCIARY TRUST CO | 23,452 | $15.6K | 3.5% | — |
| 6 | COMMONWEALTH EQUITY SERVICES, LLC | 10,313 | $6.9K | 1.6% | — |
| 7 | GROUP ONE TRADING LLC | 1,785 | $1.2K | 0.3% | — |
| 8 | HRT FINANCIAL LP | 24,741 | $16.00 | 0.0% | NEAR_EXIT -86.5% |
| 9 | CWM, LLC | 1 | $1.00 | 0.0% | — |
| 10 | BlackRock, Inc. | 1 | $1.00 | 0.0% | — |
| 11 | MORGAN STANLEY | 1 | $1.00 | 0.0% | TRIM -50.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 94,036 | 56,500 | -39.9% | $37.6K | 2026-Q1 |
| HRT FINANCIAL LP | NEAR_EXIT | 182,801 | 24,741 | -86.5% | $16.00 | 2026-Q1 |
| MORGAN STANLEY | TRIM | 2 | 1 | -50.0% | $1.00 | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 538 | 314 | -41.6% | $227.00 | 2025-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 9 | 2 | -77.8% | $2.00 | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 49,800 | 80,000 | +60.6% | $77.6K | 2025-Q3 |
| VANGUARD GROUP INC | TRIM | 194,447 | 74,919 | -61.5% | $72.7K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 22,592 | 1,323 | -94.1% | $1.3K | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 1 | 9 | +800.0% | $10.00 | 2025-Q3 |
| UBS Group AG | ADD | 11,916 | 22,592 | +89.6% | $24.6K | 2025-Q2 |
| UBS Group AG | DOUBLED | 1,874 | 11,916 | +535.9% | $14.9K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 2 | 1 | -50.0% | $2.00 | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 8,354 | 1,874 | -77.6% | $2.9K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 117 | 78 | -33.3% | $123.00 | 2024-Q4 |
| ROYAL BANK OF CANADA | TRIM | 261 | 100 | -61.7% | — | 2024-Q3 |
| MORGAN STANLEY | TRIM | 3 | 2 | -33.3% | $5.00 | 2024-Q3 |
4 unique insiders with 4 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Abecassis Michael M | Director | AWARD | 119,170 | — | — |
| Mar 31, 2026 | SCHECHTER JONATHAN | Director | AWARD | 119,170 | — | — |
| Mar 31, 2026 | WEINSTEIN ROBERT | Director | AWARD | 119,170 | — | — |
| Mar 31, 2026 | WALKER WAYNE REMELL | Director | AWARD | 119,170 | — | — |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Nov 2021): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2022-10-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-04-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 8, 2021 | HC Wainwright & Co. | INITIATE | — | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2023 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Dec 1, 2022 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Nov 1, 2022 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Mar 16, 2026
earnings_calendar
PMCB Q3 2026 Earnings Scheduled — 2026-03-16